32
Views
14
CrossRef citations to date
0
Altmetric
Articles

Systemic lupus erythematosus: the influence of disease-related and classical risk factors on intima media thickness and prevalence of atherosclerotic plaques - a preliminary report. Beneficial effect of immunosuppressive treatment on carotid intima media thickness

, Md, Phd;, , Md;, , Md, Phd;, , Md, Phd, , Md, Phd;, , Md, Phd;, , Md;, , Md, Phd;, , Ms;, , Md;, , Md;, , Md, Phd;, , Md, Phd;, , Md, Phd;, , Md, Phd; & , Md, Phd show all
Pages 169-175 | Received 13 Oct 2014, Accepted 22 Dec 2014, Published online: 23 May 2017
 

Abstract

Objective The risk of cardiovascular disease is increased in systemic lupus erythematosus (SLE). A meta-analysis showed increased carotid intima media thickness (IMT) in SLE. The aim of this study was to assess the infl uence of diff erent SLE characteristics and treatment regimens on IMT and atherosclerotic plaques.

Methods and results One hundred and three SLE patients and 95 age- and sex-matched control subjects were included in the study. IMT was measured in the common carotid arteries bilaterally. Common carotid arteries, internal carotid arteries and superfi cial femoral arteries were also screened for the presence of plaques. The presence of plaques was correlated with age (P =0.00002), male sex (P =0.034), Framingham 10-year risk score (P < 1 × 10-6), SLE duration (P =0.00006), lack of immunologic disorder (P =0.0014) and Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index (P =0.049). IMT was associated with SLE duration (P =0.002), body mass index (P =0.026), Framingham 10-year risk score (P <0.001), total cholesterol concentration (P =0.002), LDL cholesterol concentration (P =0.007), SLICC/ACR (P =0.035), hypertension (P =0.002), immunologic disorder (P =0.00008) and discontinuous treatment with immunosuppressive drugs (P =0.043).

Conclusions We found a correlation between atherosclerosis and several classical cardiovascular risk factors and disease-related factors. A benefi cial eff ect of continuous immunosuppressive treatment on IMT suggests that appropriate disease control with steroid-sparing agents may protect against atherosclerosis in SLE patients.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.